KLP Kapitalforvaltning AS Lowers Stock Position in Sotera Health Company $SHC

KLP Kapitalforvaltning AS cut its holdings in shares of Sotera Health Company (NASDAQ:SHC) by 8.3% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 30,000 shares of the company’s stock after selling 2,700 shares during the period. KLP Kapitalforvaltning AS’s holdings in Sotera Health were worth $334,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. Principal Financial Group Inc. grew its position in Sotera Health by 0.3% in the 1st quarter. Principal Financial Group Inc. now owns 352,388 shares of the company’s stock valued at $4,109,000 after buying an additional 1,037 shares during the last quarter. Optimize Financial Inc grew its position in Sotera Health by 7.7% in the 1st quarter. Optimize Financial Inc now owns 14,545 shares of the company’s stock valued at $170,000 after buying an additional 1,041 shares during the last quarter. New York State Teachers Retirement System grew its position in Sotera Health by 1.9% in the 1st quarter. New York State Teachers Retirement System now owns 59,273 shares of the company’s stock valued at $691,000 after buying an additional 1,100 shares during the last quarter. UMB Bank n.a. grew its position in Sotera Health by 112.8% in the 2nd quarter. UMB Bank n.a. now owns 2,635 shares of the company’s stock valued at $29,000 after buying an additional 1,397 shares during the last quarter. Finally, Parallel Advisors LLC grew its position in Sotera Health by 124.0% in the 2nd quarter. Parallel Advisors LLC now owns 3,340 shares of the company’s stock valued at $37,000 after buying an additional 1,849 shares during the last quarter. 91.03% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Sotera Health

In other news, Director Gtcr Investment Xi Llc sold 8,000,000 shares of Sotera Health stock in a transaction on Friday, September 5th. The stock was sold at an average price of $15.11, for a total transaction of $120,880,000.00. Following the completion of the transaction, the director owned 41,215,301 shares of the company’s stock, valued at $622,763,198.11. The trade was a 16.26% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Pincus & Co. Warburg sold 12,000,000 shares of Sotera Health stock in a transaction on Friday, September 5th. The stock was sold at an average price of $15.11, for a total value of $181,320,000.00. Following the transaction, the director directly owned 61,822,952 shares of the company’s stock, valued at $934,144,804.72. This trade represents a 16.26% decrease in their position. The disclosure for this sale can be found here. Insiders sold 20,126,611 shares of company stock valued at $304,273,888 in the last 90 days. 55.12% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of research firms recently weighed in on SHC. Weiss Ratings reiterated a “sell (d)” rating on shares of Sotera Health in a research report on Wednesday, October 8th. Barclays lifted their price objective on shares of Sotera Health from $17.00 to $19.00 and gave the company an “overweight” rating in a research report on Thursday, October 2nd. Finally, Wall Street Zen upgraded shares of Sotera Health from a “buy” rating to a “strong-buy” rating in a research report on Saturday, August 16th. Four equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Sotera Health presently has a consensus rating of “Moderate Buy” and an average price target of $17.20.

Sotera Health Price Performance

Shares of NASDAQ SHC opened at $16.16 on Monday. The firm has a market capitalization of $4.59 billion, a P/E ratio of 202.03 and a beta of 1.82. Sotera Health Company has a one year low of $9.53 and a one year high of $16.64. The company’s fifty day moving average is $15.94 and its two-hundred day moving average is $13.16. The company has a debt-to-equity ratio of 4.49, a quick ratio of 2.23 and a current ratio of 2.47.

Sotera Health (NASDAQ:SHC) last issued its earnings results on Friday, August 8th. The company reported $0.20 EPS for the quarter, topping the consensus estimate of $0.17 by $0.03. The company had revenue of $294.34 million for the quarter, compared to analyst estimates of $275.81 million. Sotera Health had a net margin of 2.14% and a return on equity of 39.42%. The business’s revenue was up 6.4% on a year-over-year basis. During the same period in the previous year, the firm earned $0.19 EPS. Sotera Health has set its FY 2025 guidance at 0.750-0.820 EPS. Analysts forecast that Sotera Health Company will post 0.61 EPS for the current fiscal year.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.